Registrational Phase 3 study for advanced melanoma immunotherapy delivered with PharmaJet's IM Needle-free System planned for ...
Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's ...
Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...
Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...
Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new study has found only about a ...
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain ...
Jennette McCurdy may have undergone the delicate and very involved procedure of freezing her eggs - but that doesn't make her ...
Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...
D spent a decade recovering from an addiction that started when he fell off a ladder, got injured and was prescribed opioid pain pills.
Testosterone is a naturally occurring steroid hormone. Despite its status as a steroid, prescription testosterone replacement ...
Nodule and lipoma formation can occur rarely after an intramuscular influenza vaccination, particularly when administered ...
FDA accepts BLA for INO-3107, a DNA immunotherapy for HPV-6 and HPV-11-associated recurrent respiratory papillomatosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results